Cargando…
The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion
BACKGROUND: Extended criteria donor lungs deemed unsuitable for immediate transplantation can be reconditioned using ex vivo lung perfusion (EVLP). Objective identification of which donor lungs can be successfully reconditioned and will function well post-operatively has not been established. This s...
Autores principales: | Andreasson, Anders S.I., Borthwick, Lee A., Gillespie, Colin, Jiwa, Kasim, Scott, Jonathan, Henderson, Paul, Mayes, Jonny, Romano, Rosalba, Roman, Marius, Ali, Simi, Fildes, James E., Marczin, Nandor, Dark, John H., Fisher, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578478/ https://www.ncbi.nlm.nih.gov/pubmed/28551353 http://dx.doi.org/10.1016/j.healun.2017.05.012 |
Ejemplares similares
-
Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion
por: Andreasson, Anders S.I., et al.
Publicado: (2017) -
Transcriptional analysis identifies potential novel biomarkers associated with successful ex‐vivo perfusion of human donor lungs
por: Ferdinand, John Robert, et al.
Publicado: (2022) -
Modeling the Effects of IL-1β-mediated Inflammation During Ex Vivo Lung Perfusion Using a Split Human Donor Model
por: Pither, Thomas, et al.
Publicado: (2023) -
ERAS in Cardiac Surgery: Wishful Thinking or Reality
por: Demir, Z. Aslı, et al.
Publicado: (2023) -
Prolonged ex-vivo normothermic kidney perfusion: The impact of perfusate composition
por: Pool, Merel B. F., et al.
Publicado: (2021)